Mycobacterium avium-M. intracellulare isolates from patients with or without acquired immunodeficiency syndrome.
Susceptibility testing and serotyping were performed on 57 isolates of Mycobacterium avium-M. intracellulare from patients with acquired immunodeficiency syndrome (AIDS) and 75 isolates from patients without AIDS. Susceptibility patterns and serotypes of AIDS isolates were significantly different from those of non-AIDS isolates. These results may partially explain the poor therapeutic response of M. avium-M. intracellulare infections in AIDS patients.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000382:microbiology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D003120:Colorado; D006801:Humans; D008396:Maryland; D008826:Microbial Sensitivity Tests; D009164:Mycobacterium Infections / Q000150:complications / Q000382:microbiology*; D009162:Mycobacterium avium / Q000145:classification / Q000187:drug effects* / Q000302:isolation & purification; D009519:New York City; D011446:Prospective Studies; D012189:Retrospective Studies; D012703:Serotyping; D014861:Washington
D000900:Anti-Bacterial Agents